Invention Grant
US09550754B2 4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy
有权
4,5-二氢吡唑衍生物，含有它们的药物组合物及其在治疗中的用途
- Patent Title: 4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy
- Patent Title (中): 4,5-二氢吡唑衍生物，含有它们的药物组合物及其在治疗中的用途
-
Application No.: US14849470Application Date: 2015-09-09
-
Publication No.: US09550754B2Publication Date: 2017-01-24
- Inventor: Wilhelm Amberg , Jason Brewer , Charles Hutchins , Udo Lange , Yanbin Lao , Huan-Qiu Li , Frauke Pohlki , Anil Vasudevan , Ying Wang , Hongyu Zhao
- Applicant: ABBVIE DEUTSCHLAND GMBH & CO. KG , ABBVIE INC.
- Applicant Address: DE Wiesbaden US IL North Chicago
- Assignee: ABBVIE DEUTSCHLAND GMBH & CO. KG,ABBVIE INC.
- Current Assignee: ABBVIE DEUTSCHLAND GMBH & CO. KG,ABBVIE INC.
- Current Assignee Address: DE Wiesbaden US IL North Chicago
- Agency: Neal, Gerber & Eisenberg LLP
- Main IPC: C07D403/12
- IPC: C07D403/12 ; C07D401/14
Abstract:
The present invention relates to 4,5-dihydropyrazole derivatives of the formula (I) and physiologically tolerated salts thereof which are GlyT1 inhibitors. The invention further relates to pharmaceutical compositions comprising such 4,5-dihydropyrazole derivatives, and the use of such 4,5-dihydropyrazole derivatives for therapeutic purposes.
Public/Granted literature
- US20160075691A1 4,5- DIHYDROPYRAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY Public/Granted day:2016-03-17
Information query
